img

Global Anti-tuberculosis Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-tuberculosis Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-tuberculosis Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-tuberculosis Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics and Government Agencies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-tuberculosis Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-tuberculosis Medicine key manufacturers include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical are top 3 players and held % sales share in total in 2022.
Anti-tuberculosis Medicine can be divided into Isoniazid, Rifampin, Ethambutol and Pyrazinamide, etc. Isoniazid is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-tuberculosis Medicine is widely used in various fields, such as Hospitals and Clinics, Government Agencies, Non-Profit Organizations and Others, etc. Hospitals and Clinics provides greatest supports to the Anti-tuberculosis Medicine industry development. In 2022, global % sales of Anti-tuberculosis Medicine went into Hospitals and Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-tuberculosis Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
Segment by Type
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr

Segment by Application


Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-tuberculosis Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-tuberculosis Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-tuberculosis Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anti-tuberculosis Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-tuberculosis Medicine introduction, etc. Anti-tuberculosis Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-tuberculosis Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Anti-tuberculosis Medicine Market Overview
1.1 Anti-tuberculosis Medicine Product Overview
1.2 Anti-tuberculosis Medicine Market Segment by Type
1.2.1 Isoniazid
1.2.2 Rifampin
1.2.3 Ethambutol
1.2.4 Pyrazinamide
1.2.5 Otherr
1.3 Global Anti-tuberculosis Medicine Market Size by Type
1.3.1 Global Anti-tuberculosis Medicine Market Size Overview by Type (2024-2034)
1.3.2 Global Anti-tuberculosis Medicine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Anti-tuberculosis Medicine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-tuberculosis Medicine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Anti-tuberculosis Medicine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Anti-tuberculosis Medicine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Anti-tuberculosis Medicine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Anti-tuberculosis Medicine Sales Breakdown by Type (2024-2024)
2 Global Anti-tuberculosis Medicine Market Competition by Company
2.1 Global Top Players by Anti-tuberculosis Medicine Sales (2024-2024)
2.2 Global Top Players by Anti-tuberculosis Medicine Revenue (2024-2024)
2.3 Global Top Players by Anti-tuberculosis Medicine Price (2024-2024)
2.4 Global Top Manufacturers Anti-tuberculosis Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-tuberculosis Medicine Market Competitive Situation and Trends
2.5.1 Anti-tuberculosis Medicine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-tuberculosis Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-tuberculosis Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-tuberculosis Medicine Market
2.8 Key Manufacturers Anti-tuberculosis Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-tuberculosis Medicine Status and Outlook by Region
3.1 Global Anti-tuberculosis Medicine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Anti-tuberculosis Medicine Historic Market Size by Region
3.2.1 Global Anti-tuberculosis Medicine Sales in Volume by Region (2024-2024)
3.2.2 Global Anti-tuberculosis Medicine Sales in Value by Region (2024-2024)
3.2.3 Global Anti-tuberculosis Medicine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Anti-tuberculosis Medicine Forecasted Market Size by Region
3.3.1 Global Anti-tuberculosis Medicine Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-tuberculosis Medicine Sales in Value by Region (2024-2034)
3.3.3 Global Anti-tuberculosis Medicine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-tuberculosis Medicine by Application
4.1 Anti-tuberculosis Medicine Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Government Agencies
4.1.3 Non-Profit Organizations
4.1.4 Others
4.2 Global Anti-tuberculosis Medicine Market Size by Application
4.2.1 Global Anti-tuberculosis Medicine Market Size Overview by Application (2024-2034)
4.2.2 Global Anti-tuberculosis Medicine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Anti-tuberculosis Medicine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-tuberculosis Medicine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Anti-tuberculosis Medicine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Anti-tuberculosis Medicine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Anti-tuberculosis Medicine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Anti-tuberculosis Medicine Sales Breakdown by Application (2024-2024)
5 North America Anti-tuberculosis Medicine by Country
5.1 North America Anti-tuberculosis Medicine Historic Market Size by Country
5.1.1 North America Anti-tuberculosis Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Anti-tuberculosis Medicine Sales in Volume by Country (2024-2024)
5.1.3 North America Anti-tuberculosis Medicine Sales in Value by Country (2024-2024)
5.2 North America Anti-tuberculosis Medicine Forecasted Market Size by Country
5.2.1 North America Anti-tuberculosis Medicine Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-tuberculosis Medicine Sales in Value by Country (2024-2034)
6 Europe Anti-tuberculosis Medicine by Country
6.1 Europe Anti-tuberculosis Medicine Historic Market Size by Country
6.1.1 Europe Anti-tuberculosis Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Anti-tuberculosis Medicine Sales in Volume by Country (2024-2024)
6.1.3 Europe Anti-tuberculosis Medicine Sales in Value by Country (2024-2024)
6.2 Europe Anti-tuberculosis Medicine Forecasted Market Size by Country
6.2.1 Europe Anti-tuberculosis Medicine Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-tuberculosis Medicine Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-tuberculosis Medicine by Region
7.1 Asia-Pacific Anti-tuberculosis Medicine Historic Market Size by Region
7.1.1 Asia-Pacific Anti-tuberculosis Medicine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-tuberculosis Medicine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Anti-tuberculosis Medicine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Anti-tuberculosis Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-tuberculosis Medicine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-tuberculosis Medicine Sales in Value by Region (2024-2034)
8 Latin America Anti-tuberculosis Medicine by Country
8.1 Latin America Anti-tuberculosis Medicine Historic Market Size by Country
8.1.1 Latin America Anti-tuberculosis Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Anti-tuberculosis Medicine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Anti-tuberculosis Medicine Sales in Value by Country (2024-2024)
8.2 Latin America Anti-tuberculosis Medicine Forecasted Market Size by Country
8.2.1 Latin America Anti-tuberculosis Medicine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-tuberculosis Medicine Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-tuberculosis Medicine by Country
9.1 Middle East and Africa Anti-tuberculosis Medicine Historic Market Size by Country
9.1.1 Middle East and Africa Anti-tuberculosis Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-tuberculosis Medicine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Anti-tuberculosis Medicine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Anti-tuberculosis Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-tuberculosis Medicine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-tuberculosis Medicine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Lupin
10.1.1 Lupin Company Information
10.1.2 Lupin Introduction and Business Overview
10.1.3 Lupin Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Lupin Anti-tuberculosis Medicine Products Offered
10.1.5 Lupin Recent Development
10.2 Macleods Pharmaceuticals
10.2.1 Macleods Pharmaceuticals Company Information
10.2.2 Macleods Pharmaceuticals Introduction and Business Overview
10.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Products Offered
10.2.5 Macleods Pharmaceuticals Recent Development
10.3 Otsuka Pharmaceutical
10.3.1 Otsuka Pharmaceutical Company Information
10.3.2 Otsuka Pharmaceutical Introduction and Business Overview
10.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Products Offered
10.3.5 Otsuka Pharmaceutical Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Johnson & Johnson Anti-tuberculosis Medicine Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Anti-tuberculosis Medicine Products Offered
10.5.5 Pfizer Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novartis Anti-tuberculosis Medicine Products Offered
10.6.5 Novartis Recent Development
10.7 Abbott
10.7.1 Abbott Company Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Abbott Anti-tuberculosis Medicine Products Offered
10.7.5 Abbott Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 AstraZeneca Anti-tuberculosis Medicine Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bayer Anti-tuberculosis Medicine Products Offered
10.9.5 Bayer Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Eli Lilly Anti-tuberculosis Medicine Products Offered
10.10.5 Eli Lilly Recent Development
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Company Information
10.11.2 GlaxoSmithKline Introduction and Business Overview
10.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Products Offered
10.11.5 GlaxoSmithKline Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Merck Anti-tuberculosis Medicine Products Offered
10.12.5 Merck Recent Development
10.13 Sanofi
10.13.1 Sanofi Company Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Sanofi Anti-tuberculosis Medicine Products Offered
10.13.5 Sanofi Recent Development
10.14 Chongqing Huapont Pharm
10.14.1 Chongqing Huapont Pharm Company Information
10.14.2 Chongqing Huapont Pharm Introduction and Business Overview
10.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Products Offered
10.14.5 Chongqing Huapont Pharm Recent Development
10.15 Shuangding Pharm
10.15.1 Shuangding Pharm Company Information
10.15.2 Shuangding Pharm Introduction and Business Overview
10.15.3 Shuangding Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Shuangding Pharm Anti-tuberculosis Medicine Products Offered
10.15.5 Shuangding Pharm Recent Development
10.16 Hongqi pharmaceutical
10.16.1 Hongqi pharmaceutical Company Information
10.16.2 Hongqi pharmaceutical Introduction and Business Overview
10.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Products Offered
10.16.5 Hongqi pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-tuberculosis Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-tuberculosis Medicine Industrial Chain Analysis
11.4 Anti-tuberculosis Medicine Market Dynamics
11.4.1 Anti-tuberculosis Medicine Industry Trends
11.4.2 Anti-tuberculosis Medicine Market Drivers
11.4.3 Anti-tuberculosis Medicine Market Challenges
11.4.4 Anti-tuberculosis Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-tuberculosis Medicine Distributors
12.3 Anti-tuberculosis Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Isoniazid
Table 2. Major Company of Rifampin
Table 3. Major Company of Ethambutol
Table 4. Major Company of Pyrazinamide
Table 5. Major Company of Otherr
Table 6. Global Anti-tuberculosis Medicine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Anti-tuberculosis Medicine Sales by Type (2024-2024) & (Kiliton)
Table 8. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US& Million)
Table 10. Global Anti-tuberculosis Medicine Market Share in Value by Type (2024-2024)
Table 11. Global Anti-tuberculosis Medicine Price by Type (2024-2024) & (US$/Ton)
Table 12. Global Anti-tuberculosis Medicine Sales by Type (2024-2034) & (Kiliton)
Table 13. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Anti-tuberculosis Medicine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Anti-tuberculosis Medicine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Anti-tuberculosis Medicine Price by Type (2024-2034) & (US$/Ton)
Table 17. North America Anti-tuberculosis Medicine Sales by Type (2024-2024) & (Kiliton)
Table 18. North America Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Anti-tuberculosis Medicine Sales (Kiliton) by Type (2024-2024)
Table 20. Europe Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Anti-tuberculosis Medicine Sales (Kiliton) by Type (2024-2024)
Table 22. Asia-Pacific Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Anti-tuberculosis Medicine Sales (Kiliton) by Type (2024-2024)
Table 24. Latin America Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Anti-tuberculosis Medicine Sales (Kiliton) by Type (2024-2024)
Table 26. Middle East and Africa Anti-tuberculosis Medicine Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Anti-tuberculosis Medicine Sales by Company (2024-2024) & (Kiliton)
Table 28. Global Anti-tuberculosis Medicine Sales Share by Company (2024-2024)
Table 29. Global Anti-tuberculosis Medicine Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Anti-tuberculosis Medicine Revenue Share by Company (2024-2024)
Table 31. Global Market Anti-tuberculosis Medicine Price by Company (2024-2024) & (US$/Ton)
Table 32. Global Anti-tuberculosis Medicine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Anti-tuberculosis Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-tuberculosis Medicine as of 2022)
Table 35. Date of Key Manufacturers Enter into Anti-tuberculosis Medicine Market
Table 36. Key Manufacturers Anti-tuberculosis Medicine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Anti-tuberculosis Medicine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Anti-tuberculosis Medicine Sales by Region (2024-2024) & (Kiliton)
Table 40. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Anti-tuberculosis Medicine Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Anti-tuberculosis Medicine Sales Market Share in Value by Region (2024-2024)
Table 43. Global Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 44. Global Anti-tuberculosis Medicine Sales by Region (2024-2034) & (Kiliton)
Table 45. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Anti-tuberculosis Medicine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Anti-tuberculosis Medicine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2034)
Table 49. Global Anti-tuberculosis Medicine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Anti-tuberculosis Medicine Sales by Application (2024-2024) & (Kiliton)
Table 51. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Anti-tuberculosis Medicine Sales Market Share in Value by Application (2024-2024)
Table 54. Global Anti-tuberculosis Medicine Price by Application (2024-2024) & (US$/Ton)
Table 55. Global Anti-tuberculosis Medicine Sales by Application (2024-2034) & (Kiliton)
Table 56. Global Anti-tuberculosis Medicine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Anti-tuberculosis Medicine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Anti-tuberculosis Medicine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Anti-tuberculosis Medicine Price by Application (2024-2034) & (US$/Ton)
Table 60. North America Anti-tuberculosis Medicine Sales by Application (2024-2024) (Kiliton)
Table 61. North America Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Anti-tuberculosis Medicine Sales by Application (2024-2024) (Kiliton)
Table 63. Europe Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Anti-tuberculosis Medicine Sales by Application (2024-2024) (Kiliton)
Table 65. Asia-Pacific Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Anti-tuberculosis Medicine Sales by Application (2024-2024) (Kiliton)
Table 67. Latin America Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Anti-tuberculosis Medicine Sales by Application (2024-2024) (Kiliton)
Table 69. Middle East and Africa Anti-tuberculosis Medicine Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Anti-tuberculosis Medicine Sales by Country (2024-2024) & (Kiliton)
Table 71. North America Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Anti-tuberculosis Medicine Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2024)
Table 74. North America Anti-tuberculosis Medicine Sales by Country (2024-2034) & (Kiliton)
Table 75. North America Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Anti-tuberculosis Medicine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Anti-tuberculosis Medicine Sales by Country (2024-2024) & (Kiliton)
Table 79. Europe Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Anti-tuberculosis Medicine Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Anti-tuberculosis Medicine Sales by Country (2024-2034) & (Kiliton)
Table 83. Europe Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Anti-tuberculosis Medicine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2024-2024) & (Kiliton)
Table 87. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2024-2034) & (Kiliton)
Table 91. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Anti-tuberculosis Medicine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Anti-tuberculosis Medicine Sales by Country (2024-2024) & (Kiliton)
Table 95. Latin America Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Anti-tuberculosis Medicine Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Anti-tuberculosis Medicine Sales by Country (2024-2034) & (Kiliton)
Table 99. Latin America Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Anti-tuberculosis Medicine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2024-2024) & (Kiliton)
Table 103. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2024-2034) & (Kiliton)
Table 107. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Value by Country (2024-2034)
Table 110. Lupin Company Information
Table 111. Lupin Introduction and Business Overview
Table 112. Lupin Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 113. Lupin Anti-tuberculosis Medicine Product
Table 114. Lupin Recent Development
Table 115. Macleods Pharmaceuticals Company Information
Table 116. Macleods Pharmaceuticals Introduction and Business Overview
Table 117. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 118. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product
Table 119. Macleods Pharmaceuticals Recent Development
Table 120. Otsuka Pharmaceutical Company Information
Table 121. Otsuka Pharmaceutical Introduction and Business Overview
Table 122. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 123. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product
Table 124. Otsuka Pharmaceutical Recent Development
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Introduction and Business Overview
Table 127. Johnson & Johnson Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 128. Johnson & Johnson Anti-tuberculosis Medicine Product
Table 129. Johnson & Johnson Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Introduction and Business Overview
Table 132. Pfizer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 133. Pfizer Anti-tuberculosis Medicine Product
Table 134. Pfizer Recent Development
Table 135. Novartis Company Information
Table 136. Novartis Introduction and Business Overview
Table 137. Novartis Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 138. Novartis Anti-tuberculosis Medicine Product
Table 139. Novartis Recent Development
Table 140. Abbott Company Information
Table 141. Abbott Introduction and Business Overview
Table 142. Abbott Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 143. Abbott Anti-tuberculosis Medicine Product
Table 144. Abbott Recent Development
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Introduction and Business Overview
Table 147. AstraZeneca Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 148. AstraZeneca Anti-tuberculosis Medicine Product
Table 149. AstraZeneca Recent Development
Table 150. Bayer Company Information
Table 151. Bayer Introduction and Business Overview
Table 152. Bayer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 153. Bayer Anti-tuberculosis Medicine Product
Table 154. Bayer Recent Development
Table 155. Eli Lilly Company Information
Table 156. Eli Lilly Introduction and Business Overview
Table 157. Eli Lilly Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 158. Eli Lilly Anti-tuberculosis Medicine Product
Table 159. Eli Lilly Recent Development
Table 160. GlaxoSmithKline Company Information
Table 161. GlaxoSmithKline Introduction and Business Overview
Table 162. GlaxoSmithKline Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 163. GlaxoSmithKline Anti-tuberculosis Medicine Product
Table 164. GlaxoSmithKline Recent Development
Table 165. Merck Company Information
Table 166. Merck Introduction and Business Overview
Table 167. Merck Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 168. Merck Anti-tuberculosis Medicine Product
Table 169. Merck Recent Development
Table 170. Sanofi Company Information
Table 171. Sanofi Introduction and Business Overview
Table 172. Sanofi Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 173. Sanofi Anti-tuberculosis Medicine Product
Table 174. Sanofi Recent Development
Table 175. Chongqing Huapont Pharm Company Information
Table 176. Chongqing Huapont Pharm Introduction and Business Overview
Table 177. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 178. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product
Table 179. Chongqing Huapont Pharm Recent Development
Table 180. Shuangding Pharm Company Information
Table 181. Shuangding Pharm Introduction and Business Overview
Table 182. Shuangding Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 183. Shuangding Pharm Anti-tuberculosis Medicine Product
Table 184. Shuangding Pharm Recent Development
Table 185. Hongqi pharmaceutical Company Information
Table 186. Hongqi pharmaceutical Introduction and Business Overview
Table 187. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 188. Hongqi pharmaceutical Anti-tuberculosis Medicine Product
Table 189. Hongqi pharmaceutical Recent Development
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Anti-tuberculosis Medicine Market Trends
Table 193. Anti-tuberculosis Medicine Market Drivers
Table 194. Anti-tuberculosis Medicine Market Challenges
Table 195. Anti-tuberculosis Medicine Market Restraints
Table 196. Anti-tuberculosis Medicine Distributors List
Table 197. Anti-tuberculosis Medicine Downstream Customers
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-tuberculosis Medicine Product Picture
Figure 2. Global Anti-tuberculosis Medicine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-tuberculosis Medicine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Anti-tuberculosis Medicine Sales Status and Outlook (2024-2034) & (Kiliton)
Figure 5. Product Picture of Isoniazid
Figure 6. Global Isoniazid Sales YoY Growth (2024-2034) & (Kiliton)
Figure 7. Product Picture of Rifampin
Figure 8. Global Rifampin Sales YoY Growth (2024-2034) & (Kiliton)
Figure 9. Product Picture of Ethambutol
Figure 10. Global Ethambutol Sales YoY Growth (2024-2034) & (Kiliton)
Figure 11. Product Picture of Pyrazinamide
Figure 12. Global Pyrazinamide Sales YoY Growth (2024-2034) & (Kiliton)
Figure 13. Product Picture of Otherr
Figure 14. Global Otherr Sales YoY Growth (2024-2034) & (Kiliton)
Figure 15. Global Anti-tuberculosis Medicine Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Anti-tuberculosis Medicine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Anti-tuberculosis Medicine Sales Market Share in Volume by Type in 2022
Figure 18. North America Anti-tuberculosis Medicine Sales Market Share in Value by Type in 2022
Figure 19. Europe Anti-tuberculosis Medicine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Anti-tuberculosis Medicine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Anti-tuberculosis Medicine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Anti-tuberculosis Medicine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-tuberculosis Medicine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-tuberculosis Medicine Revenue in 2022
Figure 29. Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Hospitals and Clinics
Figure 31. Global Hospitals and Clinics Sales YoY Growth (2024-2034) & (Kiliton)
Figure 32. Product Picture of Government Agencies
Figure 33. Global Government Agencies Sales YoY Growth (2024-2034) & (Kiliton)
Figure 34. Product Picture of Non-Profit Organizations
Figure 35. Global Non-Profit Organizations Sales YoY Growth (2024-2034) & (Kiliton)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2024-2034) & (Kiliton)
Figure 38. Global Anti-tuberculosis Medicine Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Anti-tuberculosis Medicine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Anti-tuberculosis Medicine Sales Market Share in Volume by Application in 2022
Figure 41. North America Anti-tuberculosis Medicine Sales Market Share in Value by Application in 2022
Figure 42. Europe Anti-tuberculosis Medicine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Anti-tuberculosis Medicine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Anti-tuberculosis Medicine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Anti-tuberculosis Medicine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Anti-tuberculosis Medicine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Anti-tuberculosis Medicine Manufacturing Cost Structure
Figure 51. Anti-tuberculosis Medicine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries